| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,027 | 1,151 | 835 | | Cost of Revenue | 590 | 895 | 741 | | | Gross Profit | 437 | 256 | 94 | | | Operating Expenses | | Research Development | 1,032 | 1,146 | 1,214 | | Selling General and Administrative | 2,386 | 1,935 | 1,903 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,981) | (2,825) | (3,023) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,831) | 14 | 81 | | Earnings Before Interest And Taxes | (9,812) | (2,811) | (2,942) | | Interest Expense | 921 | 230 | 32 | | Income Before Tax | (10,733) | (3,041) | (2,974) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,733) | (3,041) | (2,974) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (10,733) | (3,041) | (2,974) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,733) | ($3,041) | ($2,974) |
|
0.31% Nasdaq 
0.05%
Income Statement
